Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Anna Galstyan(Cedars-Sinai Medical Center), Julia Y. Ljubimova(Cedars-Sinai Medical Center), Ekaterina S. Shatalova(Cedars-Sinai Medical Center), Keith L. Black(Cedars-Sinai Medical Center), Janet L. Markman(Takara (United States)), Zachary B. Grodzinski(Cedars-Sinai Medical Center), Alan J. Korman(Bristol-Myers Squibb (Germany)), Dmytro Klymyshyn(Cedars-Sinai Medical Center), Eggehard Holler(Terasaki Foundation), Tao Sun(Cedars-Sinai Medical Center), Rameshwar Patil(Cedars-Sinai Medical Center), Alexander V. Ljubimov(Cedars-Sinai Medical Center), Warren G. Tourtellotte(Cedars-Sinai Medical Center), Leila A. Mashouf(Harvard University), Antonella Chiechi(Cedars-Sinai Medical Center), Hui Ding(Cedars-Sinai Medical Center), Liron L. Israel(Cedars-Sinai Medical Center), Manuel L. Penichet(University of California, Los Angeles), Vladimir A. Ljubimov(Cedars-Sinai Medical Center), Arshia Ramesh(University of California, Los Angeles), Oliver Braubach(Akoya Biosciences (United States))
Cited by 2
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
|Science|1995|1.5k
The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience
|Trends in Neurosciences|1999|461